Aura Life Science

Aura Life Science is a Chicago-based startup specializing in carbon-negative, photosynthetic biomanufacturing. The company has developed a proprietary platform that utilizes engineered cyanobacteria to convert light and carbon dioxide into high-value proteins. By leveraging photosynthetic processes, Aura's technology aims to achieve significantly higher protein yields at a lower cost compared to traditional fermentation methods that rely on agricultural feedstocks like corn or sugar. The approach is designed to be carbon-negative, removing approximately 1.6 kilograms of CO2 from the atmosphere for every kilogram of biomass produced, while simultaneously providing a secure, distributed manufacturing model that is less vulnerable to global supply chain disruptions. Founded in 2025, the company has secured foundational intellectual property and is actively collaborating with research and industry partners to scale its technology for diverse applications, including space biotechnology. By offering a sustainable alternative to conventional production, Aura Life Science addresses the growing industry demand for environmentally responsible chemical and ingredient manufacturing. The company has demonstrated proof-of-concept production for various proteins and is engaged in partnerships to further commercialize its platform. Through its participation in major startup accelerators and business plan competitions, Aura is building a strong foundation for scaling its operations and contributing to a more sustainable, resilient global biomanufacturing landscape.